Literature DB >> 15699592

Decreased expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in the kidneys of hereditary nephrotic (ICGN) mice.

Kozue Uchio-Yamada1, Noboru Manabe, Yasufumi Goto, Sayuri Anann, Yoshie Yamamoto, Kaoru Takano, Atsuo Ogura, Junichiro Matsuda.   

Abstract

Matrix metalloporoteinases (MMPs), which are dominantly regulated by tissue inhibitors of metalloproteinase (TIMPs), play important roles in extracellular matrix (ECM) degradation and are involved in the progression of kidney diseases. In glomeruli and tubulointerstitum of hereditary nephrotic (ICR-derived glomerulonephritis: ICGN) mouse kidneys, hyper-accumulation of ECM components occurred, and MMP activity decreased. In the present study, because lower levels of MMP activity may contribute to the progression of renal fibrosis in ICGN mice, Western blotting analysis and immunohistochemical staining for MMPs and TIMPs were performed to verify the expression levels of these proteins. Levels of MMP-2, MMP-9, MT1-MMP, TIMP-1 and TIMP-2 in the kidneys were decreased in ICGN mice in comparison with normal ICR mice. These results indicate that small amounts and low levels of activity of MMPs cause the progression of renal fibrosis in ICGN mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699592     DOI: 10.1292/jvms.67.35

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  7 in total

1.  Distinct metalloproteinase excretion patterns in focal segmental glomerulosclerosis.

Authors:  Kimberly A Czech; Michael Bennett; Prasad Devarajan
Journal:  Pediatr Nephrol       Date:  2011-07-01       Impact factor: 3.714

2.  Transforming growth factor-beta1 mediated up-regulation of lysyl oxidase in the kidneys of hereditary nephrotic mouse with chronic renal fibrosis.

Authors:  Yasufumi Goto; Kozue Uchio-Yamada; Sayuri Anan; Yoshie Yamamoto; Atsuo Ogura; Noboru Manabe
Journal:  Virchows Arch       Date:  2005-08-05       Impact factor: 4.064

3.  Selective inhibition of class IIa histone deacetylases alleviates renal fibrosis.

Authors:  Chongxiang Xiong; Yingjie Guan; Xiaoxu Zhou; Lirong Liu; Michelle A Zhuang; Wei Zhang; Yunhe Zhang; Monica V Masucci; George Bayliss; Ting C Zhao; Shougang Zhuang
Journal:  FASEB J       Date:  2019-04-05       Impact factor: 5.191

Review 4.  A glimpse of matrix metalloproteinases in diabetic nephropathy.

Authors:  X Xu; L Xiao; P Xiao; S Yang; G Chen; F Liu; Y S Kanwar; L Sun
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

5.  Protective effect of exogenous matrix metalloproteinase-9 on chronic renal failure.

Authors:  Lei Wang; Jue Wang; Yong Wang; Qiang Fu; Yong-Hua Lei; Zhi-Yong Nie; Jianxin Qiu; Ting-Yi Bao
Journal:  Exp Ther Med       Date:  2013-11-15       Impact factor: 2.447

Review 6.  Renal biopsy: use of biomarkers as a tool for the diagnosis of focal segmental glomerulosclerosis.

Authors:  Crislaine Aparecida da Silva; Mariana Molinar Mauad Cintra; Eliângela de Castro Côbo; Marcos Vinícius da Silva; Fabiano Bichuette Custódio; Rosana Rosa Miranda Corrêa; Lúcio Roberto Castellano; Marlene Antônia dos Reis; Juliana Reis Machado
Journal:  Dis Markers       Date:  2014-02-25       Impact factor: 3.434

Review 7.  Metastasis and MAPK Pathways.

Authors:  Mateusz Kciuk; Adrianna Gielecińska; Adrianna Budzinska; Mariusz Mojzych; Renata Kontek
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.